Skip to Content
  • Previous Rank53
  • Revenues ($M)$100,065
  • Revenue Percent Change-0.2%
  • Profits ($M)$4,517.40
  • Profits Percent Change32.7%
  • Assets ($M)$54,255.80
  • Employees26,600

In 2017, pharmacy benefits giant Express Scripts saw its net income skyrocket by 33% year-over-year to $4.51 billion. But a healthy chunk of that income—$1.38 billion—was attributable to the tax law signed by President Donald Trump late last year. While Scripts touted investments in its workforce as a result of the corporate tax cut, it also repurchased 45.9 million of its shares in a stock buyback of nearly $2.95 billion. In 2018, the company will be sure to keep an eye on potential pushback on benefits managers at large, which some critics say contribute to high drug prices because of the industry’s convoluted drug rebate structure. Express Scripts is also in the midst of a proposed $54 billion megadeal to be purchased by insurer Cigna.

Fortune Data StoreLooking for leads, investment insights, or competitive intelligence?Get Premium Access

Company Information

CEO
Timothy C. Wentworth
Sector
Health Care
Industry
Health Care: Pharmacy and Other Services
HQ Location
St. Louis
Websitehttp://www.express-scripts.com
Years on Global 500 List16
Employees26,600

Express Scripts Holding Rank History

Key Financials (Last Fiscal Year)

($ Millions)% change
Revenues ($M)$100,065-0.2%
Profits ($M)$4,517.4032.7%
Assets ($M)$54,255.80-
Total Stockholder Equity ($M)$18,119.60-

Profit Ratios

Profit as % of Revenues4.5%
Profits as % of Assets8.3%
Profits as % of Stockholder Equity24.9%